TODAY’S NEWS Pfizer and Merck – top sales forces, and overcharging New York. Harrison Ford and a movie about a biotech company. Not the next Avatar with ticket sales, apparently. Big Pharma’s messy pipeline. RECOMMENDED Simulations for training – “Live” simulations or eLearning experiences – our preferred partners can provide what you need. Contact us [...]
Archive for January, 2010
Impactiviti Daily 012910
Posted in Merck, Pfizer, Pharma, Pharma News, Pharmaceutical, Sales training, Top News, Training, Training Needs, tagged Merck, Pfizer, Simulations on January 29, 2010 | Comments Off
Impactiviti Daily 012810
Posted in AstraZeneca, Cephalon, Pfizer, Pharma, Pharma News, Pharmaceutical, Top News, Training, Web, Wyeth, tagged AstraZeneca, Cephalon, enzon, ipad, Pfizer, sigma-tau on January 28, 2010 | Comments Off
TODAY’S NEWS Pfizer trimming pipeline projects after Wyeth acquisition – Pfizer Inc., the world’s biggest drugmaker, said Wednesday it is quitting plans to sell popular pain drug Lyrica as an add-on treatment for anxiety as it shaves about 100 projects from its combined portfolio after swallowing rival Wyeth…more AstraZeneca: 8,000 more cuts coming. Ouch – [...]
Apple’s iPad and eHealth – Gamechanger?
Posted in Pharma, Pharmaceutical, Technology, Web, tagged apple, eHealth, ipad, iphone, telemedicine on January 28, 2010 | 16 Comments »
Apple just yesterday introduced the iPad, essentially an iPhone on steroids that bridges the gap between smartphones and small computers. Will this be the platform that accelerates eHealthcare on the provider side (hospitals, doctors, medical education, etc.)? I say yes. Here’s why: First of all, the pace at which doctors are using smartphones as part [...]
Impactiviti Daily 012710
Posted in Merck, Oncology, Pharma, Pharma News, Pharmaceutical, Top News, Web, tagged Merck, temodar, Teva, vitoza on January 27, 2010 | 1 Comment »
TODAY’S NEWS Merck losing Temodar patent battle with Teva – A federal court judge ruled Tuesday that a patent for Merck & Co. Inc.‘s Temodar is unenforceable, allowing Teva Pharmaceuticals USA Inc. to sell a generic version of the chemotherapy drug. Israel-based Teva, the world’s largest generic drug maker, is seeking FDA approval to sell [...]
Impactiviti Daily 012110
Posted in Biotech, J&J, Johnson and Johnson, Medicine, Merck, Pharma, Pharma News, Pharmaceutical, Top News, tagged e-detailing, HIV, Merck, MS on January 21, 2010 | Comments Off
TODAY’S NEWS Note: if you’re going to engage in questionable marketing practices, documenting it in Powerpoint is probably not a “best practice”! Just saying… Experiment HIV drug from Merck fails in late-stage studies – Merck & Co on Wednesday said its experimental HIV treatment vicriviroc proved ineffective in two late-stage studies involving patients who had [...]
Impactiviti Daily 011510
Posted in Amgen, Pfizer, Pharma, Pharma News, Pharmaceutical, Top News on January 15, 2010 | Comments Off
TODAY’S NEWS Pfizer‘s Chantix (smoke cessation product) under more legal fire for attempted suicides, deaths. Amgen‘s new drug hopes – Amgen Inc.’s 15-year search for a way to strengthen weak bones led scientists to a medicine that may stop tumors from spreading beyond soft tissue. The discovery may also help revive the company’s fortunes. U.S. [...]
Impactiviti Daily 011410
Posted in Pharma, Pharma News, Pharmaceutical, Top News, tagged Brilinta, diabetes, Plavix, Sales training, stelera on January 14, 2010 | Comments Off
TODAY’S NEWS How to do dumb insider trading – a lesson. Experimental Plavix competitor Brilinta showing improved efficacy in ACS stent patients. Enbrel competitor Stelera shows greater efficacy in psoriasis treatment. Obesity leveling off in U.S., but Diabetes is killing the economy. RECOMMENDED Management development. From full curriculum planning to workshops to targeted courses, we [...]



